Pacira Pharmaceuticals - Top 20 VC deals of 2008

Pacira Pharmaceuticals, FierceBiotech top venture capital deals of 2008Company: Pacira Pharmaceuticals
Based: San Diego, CA
Amount: $85M

Investors: Undisclosed Venture Firm, MPM Capital, OrbiMed Advisors, HBM BioVentures, Sanderling Ventures.

Scoop: In November, Pacira Pharmaceuticals extended its Series A round from the original $30 million to $85 million. The company, which is developing several drugs (mostly for pain management), is conducting clinical trials of its experimental treatment Exparel in a number of pain indications. It's also running a Phase III program for DepoBupivacaine for postsurgical pain.

Pacira Pharmaceuticals - Top 20 VC deals of 2008
Read more on

Suggested Articles

Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.

Shionogi and Hsiri Therapeutics first joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections.

The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent.